"Bile Duct Neoplasms/pathology"[MeSH] - Search Results

Year	Number of Results
1965	2
1966	2
1967	12
1968	21
1969	21
1970	21
1971	20
1972	14
1973	25
1974	23
1975	19
1976	18
1977	28
1978	26
1979	29
1980	21
1981	38
1982	46
1983	40
1984	56
1985	45
1986	57
1987	54
1988	83
1989	76
1990	69
1991	84
1992	85
1993	97
1994	86
1995	115
1996	116
1997	114
1998	114
1999	144
2000	147
2001	158
2002	152
2003	142
2004	181
2005	189
2006	232
2007	224
2008	265
2009	281
2010	298
2011	320
2012	343
2013	376
2014	459
2015	430
2016	422
2017	442
2018	457
2019	467
2020	441
2021	384
2022	542
2023	482
2024	200

1

Peroral cholangioscopy-guided biopsy with novel biopsy forceps in comprehensive cancer genomic profiling for cystic duct carcinoma.

Kawakami Y, Masaki Y, Ishigami K, Hirano T, Murota A, Sugita S, Nakase H. Kawakami Y, et al. Endoscopy. 2024 Dec;56(S 01):E414-E415. doi: 10.1055/a-2313-9930. Epub 2024 May 17. Endoscopy. 2024. PMID: 38759967 Free PMC article. No abstract available.

2

Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: A report of 3 cases and literature review.

Peng L, Peng X, Duan S, Zhang Z. Peng L, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):319-330. doi: 10.11817/j.issn.1672-7347.2024.230298. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38755729 Free PMC article. Review.

3

Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices.

Evans M, Kendall T. Evans M, et al. Expert Rev Mol Diagn. 2024 May;24(5):393-408. doi: 10.1080/14737159.2024.2353696. Epub 2024 May 16. Expert Rev Mol Diagn. 2024. PMID: 38752560 Review.

4

SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.

Luk IS, Bridgwater CM, Yu A, Boila LD, Yáñez-Bartolomé M, Lampano AE, Hulahan TS, Boukhali M, Kathiresan M, Macarulla T, Kenerson HL, Yamamoto N, Sokolov D, Engstrom IA, Sullivan LB, Lampe PD, Cooper JA, Yeung RS, Tian TV, Haas W, Saha SK, Kugel S. Luk IS, et al. Sci Transl Med. 2024 May 15;16(747):eadj7685. doi: 10.1126/scitranslmed.adj7685. Epub 2024 May 15. Sci Transl Med. 2024. PMID: 38748774

5

Noninvasive prediction of perineural invasion in intrahepatic cholangiocarcinoma by clinicoradiological features and computed tomography radiomics based on interpretable machine learning: a multicenter cohort study: erratum.

[No authors listed] [No authors listed] Int J Surg. 2024 May 1;110(5):3138. doi: 10.1097/JS9.0000000000001624. Int J Surg. 2024. PMID: 38748504 Free PMC article. No abstract available.

6

Retraction: Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish.

Yan C, Yang Q, Shen HM, Spitsbergen JM, Gong Z. Yan C, et al. Oncotarget. 2024 May 14;15:301. doi: 10.18632/oncotarget.28570. Oncotarget. 2024. PMID: 38742682 Free PMC article. No abstract available.

7

Erratum: NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.

[No authors listed] [No authors listed] Hepatol Commun. 2024 May 10;8(6):e0465. doi: 10.1097/HC9.0000000000000465. eCollection 2024 Jun 1. Hepatol Commun. 2024. PMID: 38727679 Free PMC article. No abstract available.

8

Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis.

Shichi S, Sugiyama K, Asahi Y, Shirakawa C, Nakamoto H, Kimura S, Wakizaka K, Aiyama T, Nagatsu A, Orimo T, Kakisaka T, Taketomi A. Shichi S, et al. Cancer Med. 2024 May;13(9):e7238. doi: 10.1002/cam4.7238. Cancer Med. 2024. PMID: 38716625 Free PMC article.

9

FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.

Zhen Y, Liu K, Shi L, Shah S, Xu Q, Ellis H, Balasooriya ER, Kreuzer J, Morris R, Baldwin AS, Juric D, Haas W, Bardeesy N. Zhen Y, et al. Nat Commun. 2024 May 7;15(1):3805. doi: 10.1038/s41467-024-47514-y. Nat Commun. 2024. PMID: 38714664 Free PMC article.

10

Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.

Howell TC, Rhodin KE, Shaw B, Bao J, Kanu E, Masoud S, Bartholomew AJ, Gao Q, Anwar IJ, Ladowski JM, Nussbaum DP, Blazer DG 3rd, Zani S, Allen PJ, Barbas AS, Lidsky ME. Howell TC, et al. J Gastrointest Surg. 2024 May;28(5):738-745. doi: 10.1016/j.gassur.2024.02.029. Epub 2024 Feb 22. J Gastrointest Surg. 2024. PMID: 38704208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,856 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,856 results

Results by year